• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SYNTAX 评分评估的冠状动脉粥样硬化负担与手术、经皮或药物治疗策略的结局:一项回顾性队列研究。

Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.

机构信息

Department of Atherosclerosis, Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.

Heart and Stroke/Richard Lewar Centres of Excellence in Cardiovascular Research, Peter Munk Cardiac Centre, University of Toronto, Toronto, Ontario, Canada.

出版信息

BMJ Open. 2022 Sep 22;12(9):e062378. doi: 10.1136/bmjopen-2022-062378.

DOI:10.1136/bmjopen-2022-062378
PMID:36137633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9511539/
Abstract

INTRODUCTION

Coronary atherosclerotic burden and SYNTAX Score (SS) are predictors of cardiovascular events.

OBJECTIVES

To investigate the value of SYNTAX scores (SS, SYNTAX Score II (SSII) and residual SYNTAX Score (rSS)) for predicting cardiovascular events in patients with coronary artery disease (CAD).

DESIGN

Retrospective cohort study.

SETTING

Single tertiary centre.

PARTICIPANTS

Medicine, Angioplasty or Surgery Study database patients with stable multivessel CAD and preserved ejection fraction.

INTERVENTIONS

Patients with CAD undergoing coronary artery bypass graft (CABG), percutaneous coronary intervention (PCI) or medical treatment (MT) alone from January 2002 to December 2015.

PRIMARY AND SECONDARY OUTCOMES

Primary: 5-year all-cause mortality. Secondary: composite of all-cause death, myocardial infarction, stroke and subsequent coronary revascularisation at 5 years.

RESULTS

A total of 1719 patients underwent PCI (n=573), CABG (n=572) or MT (n=574) alone. The SS was not considered an independent predictor of 5-year mortality in the PCI (low, intermediate and high SS at 6.5%, 6.8% and 4.3%, respectively, p=0.745), CABG (low, intermediate and high SS at 5.7%, 8.0% and 12.1%, respectively, p=0.194) and MT (low, intermediate and high SS at 6.8%, 6.9% and 6.5%, respectively, p=0.993) cohorts. The SSII (low, intermediate and high SSII at 3.6% vs 7.9% vs 10.5%, respectively, p<0.001) was associated with a higher mortality risk in the overall population. Within each treatment strategy, SSII was associated with a significant 5-year mortality rate, especially in CABG patients with higher SSII (low, intermediate and high SSII at 1.8%, 9.7% and 10.0%, respectively, p=0.004) and in MT patients with high SSII (low, intermediate and high SSII at 5.0%, 4.7% and 10.8%, respectively, p=0.031). SSII demonstrated a better predictive accuracy for mortality compared with SS and rSS (c-index=0.62).

CONCLUSIONS

Coronary atherosclerotic burden alone was not associated with significantly increased risk of all-cause mortality. The SSII better discriminates the risk of death.

TRIAL REGISTRATION NUMBER

ISRCTN66068876.

摘要

简介

冠状动脉粥样硬化负担和 SYNTAX 评分(SS)是心血管事件的预测因子。

目的

探讨 SYNTAX 评分(SS、SYNTAX Score II(SSII)和残余 SYNTAX 评分(rSS))在预测冠状动脉疾病(CAD)患者心血管事件中的价值。

设计

回顾性队列研究。

地点

单中心三级医院。

参与者

稳定多血管 CAD 和射血分数保留的患者的医学、血管成形术或手术研究数据库。

干预措施

2002 年 1 月至 2015 年 12 月接受冠状动脉旁路移植术(CABG)、经皮冠状动脉介入治疗(PCI)或单独药物治疗(MT)的 CAD 患者。

主要和次要结局

主要结局:5 年全因死亡率。次要结局:5 年内全因死亡、心肌梗死、卒中和随后的冠状动脉血运重建的复合终点。

结果

共有 1719 名患者接受了 PCI(n=573)、CABG(n=572)或 MT(n=574)治疗。在 PCI 患者中,SS 并不是 5 年死亡率的独立预测因素(低、中、高 SS 分别为 6.5%、6.8%和 4.3%,p=0.745)、CABG(低、中、高 SS 分别为 5.7%、8.0%和 12.1%,p=0.194)和 MT(低、中、高 SS 分别为 6.8%、6.9%和 6.5%,p=0.993)。SSII(低、中、高 SSII 分别为 3.6%、7.9%和 10.5%,p<0.001)与全人群的死亡率风险增加相关。在每种治疗策略中,SSII 与显著的 5 年死亡率相关,尤其是在 SSII 较高的 CABG 患者中(低、中、高 SSII 分别为 1.8%、9.7%和 10.0%,p=0.004)和在 SSII 较高的 MT 患者中(低、中、高 SSII 分别为 5.0%、4.7%和 10.8%,p=0.031)。与 SS 和 rSS 相比,SSII 对死亡率的预测准确性更好(c 指数=0.62)。

结论

冠状动脉粥样硬化负担本身与全因死亡率显著增加无关。SSII 更好地区分了死亡风险。

临床试验注册号

ISRCTN66068876。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/b087cfa0c1c1/bmjopen-2022-062378f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/ee4fa0a12271/bmjopen-2022-062378f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/ba6088bc5d08/bmjopen-2022-062378f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/b087cfa0c1c1/bmjopen-2022-062378f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/ee4fa0a12271/bmjopen-2022-062378f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/ba6088bc5d08/bmjopen-2022-062378f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1200/9511539/b087cfa0c1c1/bmjopen-2022-062378f03.jpg

相似文献

1
Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.SYNTAX 评分评估的冠状动脉粥样硬化负担与手术、经皮或药物治疗策略的结局:一项回顾性队列研究。
BMJ Open. 2022 Sep 22;12(9):e062378. doi: 10.1136/bmjopen-2022-062378.
2
Assessment of Predictive Value of SYNTAX-II Score for Adverse Cardiac Events and Clinical Outcomes in Patients With Acute Coronary Syndrome.急性冠状动脉综合征患者中SYNTAX-II评分对不良心脏事件和临床结局的预测价值评估
Angiology. 2024 Sep;75(8):754-763. doi: 10.1177/00033197231181958. Epub 2023 Jun 9.
3
Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.比较多种风险评分在评估行经皮冠状动脉介入治疗多支血管不稳定型心绞痛/非 ST 段抬高型心肌梗死患者的中-长期临床结局中的作用:印度一项基于观察性登记研究。
Indian Heart J. 2021 Sep-Oct;73(5):555-560. doi: 10.1016/j.ihj.2021.08.001. Epub 2021 Aug 5.
4
Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy.经皮冠状动脉介入治疗的左主干冠状动脉疾病患者中不遵循SYNTAX评分II手术推荐的影响:EXCEL子研究
Eur J Cardiothorac Surg. 2020 Apr 1;57(4):676-683. doi: 10.1093/ejcts/ezz274.
5
Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores.评估接受经皮冠状动脉介入治疗的复杂冠状动脉疾病患者的长期死亡率:多种解剖学和临床预后风险评分的比较。
EuroIntervention. 2017 Nov 20;13(10):1177-1184. doi: 10.4244/EIJ-D-16-00659.
6
ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study.在一个没有心脏外科手术设施的国家,通过SYNTAX评分II评估心肌血运重建的适宜性;PROUST研究。
Int J Cardiol. 2017 Jan 15;227:478-484. doi: 10.1016/j.ijcard.2016.11.001. Epub 2016 Nov 3.
7
Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.三支血管冠状动脉疾病的风险分层:在SYNTAX II试验的心脏团队讨论中应用SYNTAX评分II
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):E229-38. doi: 10.1002/ccd.25907. Epub 2015 May 6.
8
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial.SYNTAX 评分在 FREEDOM 试验中接受冠状动脉血运重建的糖尿病患者中的应用。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2826-2837. doi: 10.1016/j.jacc.2018.09.046.
9
Surgical and percutaneous revascularization outcomes based on SYNTAX I, II, and residual scores: a long-term follow-up study.基于 SYNTAX I、II 和残余评分的手术和经皮血运重建结果:一项长期随访研究。
J Cardiothorac Surg. 2021 Sep 3;16(1):248. doi: 10.1186/s13019-021-01616-6.
10
Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.Syntax评分II在左主干和多支冠状动脉疾病患者中的预测性能——CREDO-Kyoto注册研究分析
Circ J. 2014;78(8):1942-9. doi: 10.1253/circj.cj-14-0204. Epub 2014 Jul 7.

引用本文的文献

1
External validation of SYNTAX score II in a real-world cohort undergoing coronary artery bypass grafting.Syntax评分II在接受冠状动脉搭桥术的真实世界队列中的外部验证
J Cardiothorac Surg. 2025 Aug 7;20(1):324. doi: 10.1186/s13019-025-03572-x.
2
Impact of Peripheral Arterial Disease on Outcomes of Acute Coronary Syndrome.外周动脉疾病对急性冠状动脉综合征结局的影响。
Maedica (Bucur). 2024 Sep;19(3):470-477. doi: 10.26574/maedica.2024.19.3.470.
3
Cardiovascular Statistics - Brazil 2023.心血管统计数据 - 巴西2023年

本文引用的文献

1
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.基于冠状动脉疾病和缺血严重程度的 ISCHEMIA 试验结果。
Circulation. 2021 Sep 28;144(13):1024-1038. doi: 10.1161/CIRCULATIONAHA.120.049755. Epub 2021 Sep 9.
2
Predictive value of the SYNTAX score for diabetic retinopathy in stable coronary artery disease patients with a concomitant type 2 diabetes mellitus.SYNTAX 评分对合并 2 型糖尿病的稳定型冠状动脉疾病患者糖尿病视网膜病变的预测价值。
Diabetes Res Clin Pract. 2021 Jul;177:108875. doi: 10.1016/j.diabres.2021.108875. Epub 2021 May 29.
3
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.
Arq Bras Cardiol. 2024 Feb;121(2):e20240079. doi: 10.36660/abc.20240079.
糖尿病合并多支血管病变患者行血运重建治疗后的长期生存情况。
J Am Coll Cardiol. 2020 Sep 8;76(10):1153-1164. doi: 10.1016/j.jacc.2020.06.052.
4
Initial Invasive or Conservative Strategy for Stable Coronary Disease.稳定型冠心病的初始侵入性或保守治疗策略。
N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30.
5
Association Between Stress Testing-Induced Myocardial Ischemia and Clinical Events in Patients With Multivessel Coronary Artery Disease.多支冠状动脉疾病患者中应激试验诱发的心肌缺血与临床事件之间的关联
JAMA Intern Med. 2019 Oct 1;179(10):1345-1351. doi: 10.1001/jamainternmed.2019.2227.
6
Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.SYNTAX 评分 I 和 II 对合并多支血管病变糖尿病患者的影响:SYNTAX、PRECOMBAT 和 BEST 试验患者水平数据的汇总分析。
Eur Heart J. 2017 Jul 1;38(25):1969-1977. doi: 10.1093/eurheartj/ehx138.
7
Residual SYNTAX score following coronary artery bypass grafting.冠状动脉搭桥术后的残余SYNTAX评分
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):547-553. doi: 10.1093/ejcts/ezw356.
8
Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.多支血管病变和/或无保护左主干病变患者行冠状动脉支架置入术或旁路移植术的个体长期死亡率预测:SYNTAX II 评分模型在 BEST 和 PRECOMBAT 随机对照试验 1480 例患者中的外部验证。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1564-72. doi: 10.1016/j.jcin.2016.04.023.
9
The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.功能完全血运重建后残余冠状动脉狭窄的预后价值。
J Am Coll Cardiol. 2016 Apr 12;67(14):1701-11. doi: 10.1016/j.jacc.2016.01.056.
10
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.EXCEL 试验中依维莫司洗脱支架与冠状动脉旁路移植术治疗左主干血运重建效果的长期预测和死亡率比较:SYNTAX 评分 II 的前瞻性验证。
Eur Heart J. 2015 May 21;36(20):1231-41. doi: 10.1093/eurheartj/ehu518. Epub 2015 Jan 12.